We are live on ! Find out more
N

Nuveen Portfolio holdings

AUM $369B
1-Year Est. Return 31.66%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$254B
AUM Growth
+$235B
Cap. Flow
+$230B
Cap. Flow %
90.52%
Top 10 Hldgs %
17.14%
Holding
3,268
New
2,228
Increased
916
Reduced
59
Closed
11

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$8.24B
2
AAPL icon
Apple
AAPL
+$6.76B
3
AMZN icon
Amazon
AMZN
+$6.52B
4
META icon
Meta Platforms (Facebook)
META
+$4.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.45B

Sector Composition

Rank Sector Weight
1 Technology 18.97%
2 Financials 14.46%
3 Healthcare 12.78%
4 Consumer Discretionary 10.65%
5 Industrials 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UFI icon
2501
UNIFI
UFI
$134M
$1.73M ﹤0.01%
+95,359
New +$1.85M
DFIN icon
2502
Donnelley Financial Solutions
DFIN
$1.16B
$1.73M ﹤0.01%
+129,398
New +$1.83M
RIGL icon
2503
Rigel Pharmaceuticals
RIGL
$750M
$1.72M ﹤0.01%
+65,956
New +$1.49M
NAT icon
2504
Nordic American Tanker
NAT
$1.37B
$1.72M ﹤0.01%
+735,195
New +$1.58M
CHS
2505
DELISTED
Chicos FAS, Inc.
CHS
$1.72M ﹤0.01%
+510,592
New +$1.86M
PML
2506
PIMCO Municipal Income Fund II
PML
$493M
$1.71M ﹤0.01%
114,525
BHB icon
2507
Bar Harbor Bankshares
BHB
$666M
$1.71M ﹤0.01%
+64,128
New +$1.64M
PETX
2508
DELISTED
Aratana Therapeutics, Inc.
PETX
$1.7M ﹤0.01%
+329,494
New +$1.48M
RYTM icon
2509
Rhythm Pharmaceuticals
RYTM
$7.96B
$1.7M ﹤0.01%
+77,185
New +$1.95M
CBIO
2510
Crescent Biopharma
CBIO
$626M
$1.69M ﹤0.01%
+1,418
New +$1.7M
CCNE icon
2511
CNB Financial Corp
CCNE
$1.03B
$1.69M ﹤0.01%
+59,800
New +$1.61M
DERM
2512
DELISTED
Dermira, Inc.
DERM
$1.69M ﹤0.01%
+176,443
New +$1.9M
IMKTA icon
2513
Ingles Markets
IMKTA
$1.67B
$1.68M ﹤0.01%
+53,948
New +$1.59M
HAYN
2514
DELISTED
Haynes International, Inc.
HAYN
$1.67M ﹤0.01%
+52,570
New +$1.69M
RC
2515
Ready Capital
RC
$308M
$1.67M ﹤0.01%
+112,149
New +$1.66M
BKS
2516
DELISTED
Barnes & Noble
BKS
$1.67M ﹤0.01%
+248,814
New +$1.36M
BH icon
2517
Biglari Holdings Class B
BH
$1.21B
$1.66M ﹤0.01%
+15,979
New +$1.91M
TG icon
2518
Tredegar Corp
TG
$310M
$1.66M ﹤0.01%
+99,643
New +$1.68M
CTO
2519
CTO Realty Growth
CTO
$815M
$1.65M ﹤0.01%
101,818
+78,601
+339% +$1.29M
RILY icon
2520
BRC Group Holdings
RILY
$289M
$1.65M ﹤0.01%
+79,095
New +$1.51M
CNSL
2521
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$1.65M ﹤0.01%
+334,640
New +$2.13M
KIDS icon
2522
OrthoPediatrics
KIDS
$595M
$1.64M ﹤0.01%
+42,112
New +$1.7M
RAD
2523
DELISTED
Rite Aid Corporation
RAD
$1.64M ﹤0.01%
+204,854
New +$1.77M
PZN
2524
DELISTED
Pzena Investment Management, Inc. Class A
PZN
$1.64M ﹤0.01%
+190,777
New +$1.73M
ROCC
2525
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
$1.63M ﹤0.01%
+53,275
New +$1.98M

Similar funds

Nuveen's Q2 2019 Portfolio in Review

As of Q2 2019, Nuveen held 3,268 positions worth $254B, up 1,256% from $18.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Nuveen deployed $230B of net new capital in Q2 2019, opening 2,228 new positions and adding to 916 existing holdings. Its largest new stake was Netflix: 33,941,080 shares worth $1.25B.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares iBoxx $ High Yield Corporate Bond ETF, an estimated $142M trimmed.

  • Nuveen's largest Q2 2019 buy was Netflix: 33,941,080 shares worth $1.25B.
  • Nuveen added most to Microsoft in Q2 2019, an estimated $8.24B increase.
  • Nuveen's biggest Q2 2019 reduction was iShares iBoxx $ High Yield Corporate Bond ETF, cutting an estimated $142M.
  • Nuveen fully exited Nuveen ESG Large-Cap Value ETF in Q2 2019, selling an estimated $22M.
  • Nuveen's ten largest holdings make up 17% of its $254B portfolio in Q2 2019.
  • Nuveen opened 2,228 new positions and closed 11 in Q2 2019.
  • Nuveen's portfolio value rose 1,256% quarter-over-quarter to $254B.

Based on Nuveen's 13F filing for Q2 2019, filed 15 Aug 2019.